Comparative Assessment of Docking Programs for Docking and Virtual Screening of Ribosomal Oxazolidinone Antibacterial Agents.

Buckley, McKenna E; Ndukwe, Audrey R N; Nair, Pramod C; Rana, Santu; Fairfull-Smith, Kathryn E; Gandhi, Neha S

Buckley, McKenna E; Ndukwe, Audrey R N; Nair, Pramod C; Rana, Santu; Fairfull-Smith, Kathryn E; Gandhi, Neha S.

Afiliación

Buckley ME; Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Ndukwe ARN; School of Chemistry and Physics, Queensland University of Technology, Brisbane, QLD 4000, Australia.
Nair PC; School of Chemistry and Physics, Queensland University of Technology, Brisbane, QLD 4000, Australia.
Rana S; Centre for Materials Science, Queensland University of Technology, Brisbane, QLD 4000, Australia.
Fairfull-Smith KE; Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia.
Gandhi NS; Flinders Health and Medical Research Institute (FHMRI), Flinders University, Adelaide, SA 5042, Australia.

Antibiotics (Basel) ; 12(3)2023 Feb 24.

Article en En | MEDLINE | ID: mdl-36978331

Palabras clave

DOCK 6; Vina; antibiotics; molecular docking; oxazolidinones; rRNA; re-scoring; ribosomes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Antibiotics (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google